3,138
Participants
Start Date
January 31, 2010
Primary Completion Date
August 31, 2010
Study Completion Date
August 31, 2010
Influenza Vaccine
surface antigen, inactivated, prepared in cell cultures
Influenza Vaccine
surface antigen, inactivated, prepared in egg (influvac ®)
Influenza Vaccine
surface antigen, inactivated, prepared in cell cultures
Influenza Vaccine
surface antigen, inactivated, prepared in cell cultures
Site Reference ID/Investigator# 44656, Grafton
Site Reference ID/Investigator# 44648, Maroubra Junction
Site Reference ID/Investigator# 44663, Hornsby
Site Reference ID/Investigator# 44651, Blacktown
Site Reference ID/Investigator# 44659, Blacktown
Site Reference ID/Investigator# 44647, Broadmeadow
Site Reference ID/Investigator# 44655, Rotorua
Site Reference ID/Investigator# 44654, Tauranga
Site Reference ID/Investigator# 44644, Malvern East
Site Reference ID/Investigator# 44650, Herston
Site Reference ID/Investigator# 44645, Kippa-Ring
Site Reference ID/Investigator# 44662, Auchenflower
Site Reference ID/Investigator# 44643, Sherwood
Site Reference ID/Investigator# 44646, Carina Heights
Site Reference ID/Investigator# 44649, Caboolture
Site Reference ID/Investigator# 44652, Adelaide
Site Reference ID/Investigator# 44657, Wellington
Site Reference ID/Investigator# 44658, Dunedin
Site Reference ID/Investigator# 44653, Christchurch
Lead Sponsor
Quintiles, Inc.
INDUSTRY
Abbott Biologicals
INDUSTRY